Harmony Biosciences Holdings Inc Ordinary Shares HRMY

Morningstar Rating
$39.79 +2.50 (6.70%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HRMY is trading at a 558% premium.
Price
$39.65
Fair Value
$42.28
Uncertainty
High
1-Star Price
$98.58
5-Star Price
$16.93
Economic Moat
Wxyn
Capital Allocation

News

Trading Information

Previous Close Price
$37.29
Day Range
$37.6439.95
52-Week Range
$18.6139.95
Bid/Ask
$38.16 / $41.77
Market Cap
$2.26 Bil
Volume/Avg
895,703 / 400,716

Key Statistics

Price/Earnings (Normalized)
10.88
Price/Sales
3.56
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
4.42%

Company Profile

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
246

Comparables

Valuation

Metric
HRMY
FULC
EWTX
Price/Earnings (Normalized)
10.88
Price/Book Value
4.200.914.77
Price/Sales
3.563.08
Price/Cash Flow
11.11
Price/Earnings
HRMY
FULC
EWTX

Financial Strength

Metric
HRMY
FULC
EWTX
Quick Ratio
2.9321.8429.79
Current Ratio
3.1322.0730.24
Interest Coverage
6.17
Quick Ratio
HRMY
FULC
EWTX

Profitability

Metric
HRMY
FULC
EWTX
Return on Assets (Normalized)
26.26%−1.76%−23.23%
Return on Equity (Normalized)
42.80%−1.91%−24.43%
Return on Invested Capital (Normalized)
31.24%−1.83%−29.19%
Return on Assets
HRMY
FULC
EWTX

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk AS ADR
NVO
GftyfbhszBsrcv$554.5 Bil
Vertex Pharmaceuticals Inc
VRTX
LbswntjmyKvlpdw$119.5 Bil
Regeneron Pharmaceuticals Inc
REGN
JkwzqrtZzwmnkn$114.6 Bil
Alnylam Pharmaceuticals Inc
ALNY
ZcjtjggwVnrtpp$35.2 Bil
argenx SE ADR
ARGX
SgzwkbpmwCpxy$31.7 Bil
BioNTech SE ADR
BNTX
QqnxdjrHnqf$28.0 Bil
Moderna Inc
MRNA
YbyvsjhxTyzg$24.6 Bil
United Therapeutics Corp
UTHR
GmwkyppDjnh$15.9 Bil
Biomarin Pharmaceutical Inc
BMRN
WjblpbfDcdfzp$13.4 Bil
Royalty Pharma PLC Class A
RPRX
GqxgbhwxyrVyzzr$12.6 Bil

Sponsor Center